XML 13 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:    
Net Loss $ (51,898) $ (15,043)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 38,749 40,799
Deferred financing costs amortization 890 1,300
Stock-based compensation expense 4,836 4,490
Debt discount amortization 5,980 4,899
Allowance for credit losses 144 3,253
Gain from equipment sales, retirements or impairments (1,857) (3,352)
Loss on debt extinguishment 0 177
Derivative losses 372 0
Interest on finance leases 1 201
Settlement on derivative transactions, net 164 577
Currency losses 2,357 857
Deferred income taxes (8,916) (7,701)
Equity earnings (878) (3,182)
Dividends received from 50% or less owned companies 2,916 2,075
Changes in Operating Assets and Liabilities:    
Accounts receivables (10,049) (13,743)
Other assets (2,653) 1,555
Accounts payable and accrued liabilities 1,052 (6,732)
Net cash (used in) provided by operating activities (18,790) 10,430
Cash Flows from Investing Activities:    
Purchases of property and equipment (4,284) (6,960)
Proceeds from disposition of property and equipment 2,417 8,038
Principal payments on notes due from others 0 15,000
Net cash (used in) provided by investing activities (1,867) 16,078
Cash Flows from Financing Activities:    
Payments on long-term debt (21,833) (22,992)
Payments on debt extinguishment 0 (131,604)
Payments on debt extinguishment cost 0 (1,827)
Proceeds from issuance of long-term debt, net of issuance costs 0 148,388
Payments on finance leases (28) (522)
Proceeds from exercise of stock options 140 6
Tax withholdings on restricted stock vesting and director share awards (3,889) (2,368)
Net cash used in financing activities (25,610) (10,919)
Effects of Exchange Rate Changes on Cash, Restricted Cash and Cash Equivalents 0 2
Net Change in Cash, Restricted Cash and Cash Equivalents (46,267) 15,591
Cash, Restricted Cash and Cash Equivalents, Beginning of Period 84,131 43,045
Cash, Restricted Cash and Cash Equivalents, End of Period 37,864 58,636
Supplemental disclosures:    
Cash paid for interest, excluding capitalized interest 21,925 21,045
Income taxes paid, net 50 1,730
Noncash Investing and Financing Activities:    
(Decrease) increase in capital expenditures in accounts payable and accrued liabilities (1,100) 826
Recognition of a new right-of-use asset - operating leases 0 348
Recognition of a new right-of-use asset - financing leases $ 7 $ 0